跳轉至內容
Merck
全部照片(1)

文件

SML0797

Sigma-Aldrich

氟班色林

≥98% (HPLC)

同義詞:

1,3-二氢-1-[2-[4-[3-(三氟甲基)苯基]-1-哌嗪基]乙基]-2H-苯并咪唑-2-酮, BIMT 17, BIMT 17BS

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C20H21F3N4O
CAS號碼:
分子量::
390.40
分類程式碼代碼:
12352200
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

powder

顏色

white to beige

溶解度

DMSO: 10 mg/mL, clear

儲存溫度

2-8°C

InChI

1S/C20H21F3N4O/c21-20(22,23)15-5-7-16(8-6-15)26-12-9-25(10-13-26)11-14-27-18-4-2-1-3-17(18)24-19(27)28/h1-8H,9-14H2,(H,24,28)

InChI 密鑰

CCIZQGRSEAHATK-UHFFFAOYSA-N

生化/生理作用

氟班色林是 5-HT1A 受体激动剂和 5-HT2A 受体拮抗剂。氟班色林对人 5-HT1A受体 (Ki = 1 nm) 具有高亲和力,对 5-HT2A (Ki = 49 nm) 和 D4 (Ki = 4–24 nm) 受体亲和力较低,对多种其他神经递质受体和离子通道的亲和力可忽略不计。氟班色林被用作女性绝经前性欲减退 (HSDD) 的一种新型非激素治疗方法。氟班色林。最近,在帕金森氏病模型中发现氟班色林可减轻 L-DOPA 引起的运动障碍。

特點和優勢

这种化合物是神经科学研究的特色产品。点击此处发现更多特色神经科学产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。

象形圖

Skull and crossbones

訊號詞

Danger

危險分類

Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

標靶器官

Respiratory system

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Min-Yong Low et al.
Journal of pharmaceutical and biomedical analysis, 57, 104-108 (2011-10-01)
A health supplement used for female sexual performance enhancement was sent to Health Sciences Authority of Singapore for testing. An unknown compound was detected and isolated from the health supplement and its structure was elucidated using LC-DAD, LC-FTMS, NMR and
[When women complain about lacking libido. The problem with the desire].
Katharina Arnheim
MMW Fortschritte der Medizin, 152(34-35), 12-13 (2010-10-07)
Evan R Goldfischer et al.
The journal of sexual medicine, 8(11), 3160-3172 (2011-09-22)
Flibanserin is a 5-HT(1A) agonist/5-HT(2A) antagonist that has been shown to increase sexual desire and reduce distress in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD). To assess the efficacy and safety of flibanserin over 24 weeks of double-blind treatment
Resurgence of interest in sexual dysfunction?
Mike G Wyllie
BJU international, 109(11), E36-E37 (2012-05-09)
Iñaki F Trocóniz et al.
Pharmaceutical research, 29(6), 1518-1529 (2012-01-06)
Flibanserin is being developed for treating hypoactive sexual desire disorder in women; the main side effect is sedation. The analysis objective was to relate flibanserin plasma concentrations with acute sedative effects using a population pharmacokinetic/pharmacodynamic (PK/PD) model. The population model

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務